دورية أكاديمية
Laboratory evaluation of lipid parameters in clinical practice.
| العنوان: | Laboratory evaluation of lipid parameters in clinical practice. |
|---|---|
| المؤلفون: | Pancholia AK; Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh, India. Electronic address: drpancholia@gmail.com., Kabra NK; Department of Cardiology, Gandhi Medical College and Hospital, Hyderabad, Telangana, India. Electronic address: nitink99@yahoo.com., Gupta R; Department of Preventive Cardiology & Medicine, Eternal Heart Care Centre & Research Institute, Jaipur, Rajasthan, India. Electronic address: rajeevgg@gmail.com. |
| المصدر: | Indian heart journal [Indian Heart J] 2024 Mar; Vol. 76 Suppl 1, pp. S29-S32. Date of Electronic Publication: 2024 Feb 29. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: India NLM ID: 0374675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-3763 (Electronic) Linking ISSN: 00194832 NLM ISO Abbreviation: Indian Heart J Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2012- : Amsterdam : Elsevier Original Publication: Calcutta : Cardiological Society of India |
| مواضيع طبية MeSH: | Laboratories* , Coronary Artery Disease*/diagnosis, Humans ; Cholesterol, LDL ; Cholesterol ; Triglycerides ; Cholesterol, HDL ; Risk Factors |
| مستخلص: | Accurate measurement of various lipids- total cholesterol, cholesterol lipoproteins and triglycerides- is important for coronary artery disease (CAD) prevention and management. Over the years many technologies have developed for their accurate measurements and in recent years the assays have been internationally standardised. Most of the guidelines recommend measurement of non fasting levels of total cholesterol, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C) and triglycerides (TG) for risk estimation and guiding treatment. Measurement of lipid profile in clinics and emergency departments can lead to earlier estimation of CAD risk and rapid initiation of lipid lowering therapy. CAD risk and baseline levels of LDL-C guide intensity of lipid lowering therapies. The LDL-C targets according to CAD risk are detailed in this review. There is an urgent need for standardization of lipid estimation in medical laboratories across the country so that every eligible individual can receive evidence-based lipid lowering interventions. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financialinterests or personal relationships that could have appeared to influencethe work reported in this paper. (Copyright © 2024 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. All rights reserved.) |
| References: | Indian Heart J. 2020 Mar - Apr;72(2):65-69. (PMID: 32534692) Circulation. 2018 Jul 3;138(1):e1-e34. (PMID: 29794080) Eur Heart J. 2010 Dec;31(23):2844-53. (PMID: 20965889) Pathology. 2019 Feb;51(2):148-154. (PMID: 30595507) Eur Heart J. 2022 Oct 14;43(39):3925-3946. (PMID: 36036785) Lancet. 2019 Aug 24;394(10199):685-696. (PMID: 31448740) Eur Heart J. 2016 Oct 14;37(39):2999-3058. (PMID: 27567407) Indian Heart J. 2023 Sep-Oct;75(5):327-334. (PMID: 37633460) Int J Epidemiol. 2020 Feb 1;49(1):4-14. (PMID: 32244255) J Assoc Physicians India. 2016 Mar;64(3 suppl):7-52. (PMID: 28762263) Circulation. 2023 Aug 29;148(9):e9-e119. (PMID: 37471501) Eur Heart J. 2017 Aug 21;38(32):2459-2472. (PMID: 28444290) Eur Heart J. 2020 Jan 1;41(1):111-188. (PMID: 31504418) Eur Heart J. 2020 Jun 21;41(24):2313-2330. (PMID: 32052833) Lancet. 2010 May 8;375(9726):1634-9. (PMID: 20452521) JAMA. 2009 Nov 11;302(18):1993-2000. (PMID: 19903920) Circulation. 2019 Jun 18;139(25):e1082-e1143. (PMID: 30586774) J Pharm Pract. 2017 Aug;30(4):451-458. (PMID: 27121870) Lancet. 2007 Dec 1;370(9602):1829-39. (PMID: 18061058) Br J Gen Pract. 2012 Mar;62(596):e224-6. (PMID: 22429442) Lancet. 2012 Aug 11;380(9841):581-90. (PMID: 22607822) Clin Chem. 1972 Jun;18(6):499-502. (PMID: 4337382) J Am Coll Cardiol. 2015 Jun 2;65(21):2267-75. (PMID: 26022813) Curr Opin Lipidol. 2021 Aug 1;32(4):226-230. (PMID: 33870931) Indian Heart J. 2019 May - Jun;71(3):184-198. (PMID: 31543191) J Am Coll Cardiol. 2009 Jan 27;53(4):316-22. (PMID: 19161879) |
| فهرسة مساهمة: | Keywords: Laboratory; Lipid; NABL; Non fasting; Standardization |
| المشرفين على المادة: | 0 (Cholesterol, LDL) 97C5T2UQ7J (Cholesterol) 0 (Triglycerides) 0 (Cholesterol, HDL) |
| تواريخ الأحداث: | Date Created: 20240302 Date Completed: 20240412 Latest Revision: 20240425 |
| رمز التحديث: | 20240425 |
| مُعرف محوري في PubMed: | PMC11019328 |
| DOI: | 10.1016/j.ihj.2024.02.002 |
| PMID: | 38431087 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 2213-3763 |
|---|---|
| DOI: | 10.1016/j.ihj.2024.02.002 |